Hodgkins Lymphoma

Lymphoma is a type of cancer arising from B cell lymphocytes that usually circulate in the lymphatic system and grow within lymph nodes. There are two main types – Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.

Risk Factors


  • Epstein-Barr (EBV) infection
  • Autoimmune diseases e.g. Reumatoid arthritis, coeliac disease, SLE
  • Immunosuppression e.g. drugs, history of organ/stem cell transplant, HIV
  • Family history
  • Cigarette smoking

Pathophysiology


  1. Hodgkin’s lymphoma is a cancer derived from B cell lymphocytes
     
  2. The diagnostic feature of Hodgkin’s lymphoma is the presence of the Reed-Sternberg cell histopathologically. These are abnormal, large, neoplastic cells with two large nuclei which look like owl eyes.
     
  3. The underlying pathophysiology is poorly understood for Hodgkin’s lymphoma, but one theory suggests Reed Sternberg cells form from pre-apoptotic B cells which evade programmed cell death.
     
  4. Reed Sternberg cells are thought to be able to secrete various cytokines, growth factors and chemokines that allows them to recruit other cells and form a specific microenvironment. This microenvironment in turn likely helps support survival of these cells as well as helping evade anti-tumour immune mechanisms.

Unknown authorUnknown author, Public domain, via Wikimedia Commons

Reed Sternberg Cell

Clinical Features


  • Painless lymphadenopathy: These can be anywhere in the body, including the cervical region, axilla, inguinal region etc. They usually feel rubbery on palpation.
  • B Symptoms:
    • Fever: This can be in the form of the Pel Ebstein fever which is a few days of high fever alternating with days/weeks of normal temperature
    • Drenching night sweats
    • Unexplained weight loss
  • Loss of appetite
  • Pruritus
  • Fatigue
  • Alcohol Induced Lymph Node Pain
  • Mediastinal mass effects (from enlarged mediastinal lymph nodes)
    • Chest pain
    • Cough
    • Shortness of breath
  • Age: Hodgkin Lymphoma has a bimodal distribution in that it affects younger people (15-39) and older adults (>75 years)

Investigations


Bloods

  • FBC: WCC can be high or low. A low haemoglobin suggests high cell turnover and is a poor prognostic indicator.
  • LDH: Often raised in Hodgkin’s lymphoma but this isn’t specific as it can go up in other conditions as well
  • LFT: May be deranged if there is hepatic involvement
  • ESR: May be raised
  • Blood film: To visualise Reed-Sternberg cells

Imaging

  • Chest X ray
    • Masses
    • Mediastinal lymph nodes
  • CT Thorax, Abdomen and Pelvis
    • Staging scan
    • Involvement of lymph nodes in the chest, abdomen, or pelvis.
    • Shows distant metastasis to liver, lungs etc
  • PET Scan

Special Tests

  • Biopsy of lymph nodes to visualise Reed-Sternberg cells

Differential Diagnosis


  • Reactive lymphadenopathy: Usually painful, may be associated with recent viral illness
  • Infectious mononucleosis
  • Lymphadenopathy from another malignancy e.g. breast cancer
  • Non-Hodgkin’s lymphoma

Staging


The Ann Arbor system is used to stage lymphoma.

  • I: Confined to 1 area of lymph nodes
  • II: 2 or more nodal areas involved but on the same side of the diaphragm
  • III: Involvement of nodes on both sides of the diaphragm
  • IV: Spread beyond lymph nodes e.g. liver

Each stage is associated with either A or B.

A = No systemic symptoms other than itching

B = Weight loss >10% in 6 months, unexplained fever >38, or night sweats (the presence of B symptoms)

Management


Chemotherapy and radiotherapy are the mainstay of treatment for Hodgkin’s lymphoma.

The main chemotherapy regimen used is the ABVD regimen of Adriamycin/Bleomycin/Vinblastine/Dacarbazine.

Prognosis


Prognosis varies depending on many factors including disease stage. Stage 1 is thought to have a 5-year survival of 90%, whilst stage 4 having a 70% 5-year survival rate. These numbers vary based on source.

References


https://www.msdmanuals.com/en-gb/professional/hematology-and-oncology/lymphomas/hodgkin-lymphoma#v975458

https://www.pathologyoutlines.com/topic/lymphomanonBclassic.html

https://www.ncbi.nlm.nih.gov/books/NBK499969/

https://www.nature.com/articles/s41375-021-01204-6

https://www.cdc.gov/cancer/lymphoma/index.htm

https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/survival